Inhibition of CXCR4-dependent HIV-1 infection by extracellular HIV-1 Tat
about
Selective CXCR4 antagonism by Tat: implications for in vivo expansion of coreceptor use by HIV-1Role of Oxidative Stress in HIV-1-Associated Neurocognitive Disorder and Protection by Gene Delivery of Antioxidant EnzymesHIV-1 clade B Tat, but not clade C Tat, increases X4 HIV-1 entry into resting but not activated CD4+ T cells.Similarity in viral and host promoters couples viral reactivation with host cell migrationHIV-1 inhibits autophagy in bystander macrophage/monocytic cells through Src-Akt and STAT3.Molecular Mechanisms of Neurodegenerative Diseases Induced by Human Retroviruses: A Review.Regional heterogeneity and diversity in cytokine and chemokine production by astroglia: differential responses to HIV-1 Tat, gp120, and morphine revealed by multiplex analysisViral exploitation and subversion of the immune system through chemokine mimicry.The ins and outs of HIV-1 Tat.Phage display-directed discovery of LEDGF/p75 binding cyclic peptide inhibitors of HIV replication.Novel multi-component nanopharmaceuticals derived from poly(ethylene) glycol, retro-inverso-Tat nonapeptide and saquinavir demonstrate combined anti-HIV effectsNew anti-HIV agents and targets.Preferential vulnerability of astroglia and glial precursors to combined opioid and HIV-1 Tat exposure in vitro.Transactivation and signaling functions of Tat are not correlated: biological and immunological characterization of HIV-1 subtype-C Tat protein.Chemokine receptors: emerging opportunities for new anti-HIV therapies.T-cell and neuronal apoptosis in HIV infection: implications for therapeutic intervention.Oxidative Stress Is Associated with Neuroinflammation in Animal Models of HIV-1 Tat Neurotoxicity.Mitogen-activated protein kinase p38 in HIV infection and associated brain injury.Insight into the mechanisms of aminoglycoside derivatives interaction with HIV-1 entry steps and viral gene transcription.Synaptodendritic injury with HIV-Tat protein: What is the therapeutic target?Suppressor of cytokine signaling 3 inhibits antiviral IFN-beta signaling to enhance HIV-1 replication in macrophages.Human immunodeficiency virus-associated depression: contributions of immuno-inflammatory, monoaminergic, neurodegenerative, and neurotrophic pathways.Development of a novel AIDS vaccine: the HIV-1 transactivator of transcription protein vaccine.The HIV-1 Tat protein selectively enhances CXCR4 and inhibits CCR5 expression in megakaryocytic K562 cells.Syndecan-1 increases B-lymphoid cell extravasation in response to HIV-1 Tat via αvβ3/pp60src/pp125FAK pathway.Phosphatidylinositol-(4,5)-bisphosphate enables efficient secretion of HIV-1 Tat by infected T-cells.Cannabinoid inhibits HIV-1 Tat-stimulated adhesion of human monocyte-like cells to extracellular matrix proteins.Breaking in and busting out: cell-penetrating peptides and the endosomal escape problem."cART intensification by the HIV-1 Tat B clade vaccine: progress to phase III efficacy studies".
P2860
Q24673389-71345C3D-0133-4F55-BF1C-E0E60BB734D9Q26829535-851BB929-0AC7-412E-B301-980704FA3F9DQ33581852-6A45B7F3-25BE-4530-95A8-B6CB7BA87C6CQ33640033-F109FBBE-5479-4D39-8311-306A49CD5761Q33641330-1AFEE54E-1892-4FC3-B3FE-564834CC1A58Q33753132-45E522B2-9426-4D07-A932-2137668737DEQ33797852-EB4BDA58-BC74-4629-BCDC-93BFCEBB1884Q33933260-606905A9-627F-4B66-B2E3-11221515A68FQ34219706-3819CBEB-ACC9-4342-877F-08FCD888053BQ34350400-78499904-EC11-4B16-A13D-FC339E3172FCQ34691351-A793087A-1BA9-40A3-93F4-C7BAD11FB478Q34944447-40FF4F38-4662-46FA-98A0-6754D4A2C52FQ35009483-8853734B-B02B-4CD8-A939-A58445A2DD85Q35024694-8D2627DF-6257-4DB0-9248-4BC2B3C188A6Q35050395-DB71D813-B864-4E77-8EB1-4BAAE8E4490EQ35613792-F3AC7AE5-C7EC-43DC-8E13-44AAC04FB895Q36335033-C82D9844-FF3C-4192-A2E9-CA553365A902Q36950000-AAA061F5-73FF-48A5-8162-6BD38B268FD9Q37273867-4C5B58E4-A696-44E9-A06E-D99DB81D13F2Q37597459-AD58A611-09D9-4D9B-8817-D2F29B5C71F1Q37605089-E794FB7D-7D6D-4340-B7D2-C16E2FC79D82Q38122650-2350FC91-0E2A-44D5-B683-DF8DE3D2308CQ38533881-D055A233-0F9D-4F43-ABBD-8341092B590CQ40369884-09DD8DB9-2474-434C-B947-8502659275ACQ40486626-CF6FD15E-E003-46C5-9E4A-183E7E220FABQ40508633-F62B79BE-FE9E-40B4-8871-F2A33B615F53Q41864447-A52898C1-FBED-4B79-A337-25C2DC0689ECQ42255378-253F7A19-87CD-41EF-87A5-3F0B1E4A5816Q46698274-1F9661E7-B063-4D49-8E66-5015041F452E
P2860
Inhibition of CXCR4-dependent HIV-1 infection by extracellular HIV-1 Tat
description
2000 nî lūn-bûn
@nan
2000 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Inhibition of CXCR4-dependent HIV-1 infection by extracellular HIV-1 Tat
@ast
Inhibition of CXCR4-dependent HIV-1 infection by extracellular HIV-1 Tat
@en
Inhibition of CXCR4-dependent HIV-1 infection by extracellular HIV-1 Tat
@en-gb
Inhibition of CXCR4-dependent HIV-1 infection by extracellular HIV-1 Tat
@nl
type
label
Inhibition of CXCR4-dependent HIV-1 infection by extracellular HIV-1 Tat
@ast
Inhibition of CXCR4-dependent HIV-1 infection by extracellular HIV-1 Tat
@en
Inhibition of CXCR4-dependent HIV-1 infection by extracellular HIV-1 Tat
@en-gb
Inhibition of CXCR4-dependent HIV-1 infection by extracellular HIV-1 Tat
@nl
prefLabel
Inhibition of CXCR4-dependent HIV-1 infection by extracellular HIV-1 Tat
@ast
Inhibition of CXCR4-dependent HIV-1 infection by extracellular HIV-1 Tat
@en
Inhibition of CXCR4-dependent HIV-1 infection by extracellular HIV-1 Tat
@en-gb
Inhibition of CXCR4-dependent HIV-1 infection by extracellular HIV-1 Tat
@nl
P2093
P50
P356
P1476
Inhibition of CXCR4-dependent HIV-1 infection by extracellular HIV-1 Tat
@en
P2093
D M Noonan
G Vallanti
J D Reeves
M G Aluigi
P356
10.1006/BBRC.2000.2523
P407
P577
2000-04-21T00:00:00Z